3.1 Chemical Injury, Conjunctival
Date of last review:
7/9/2026
Date of next review:
7/9/2028
Date of publication:
16/9/2026
Differential diagnosis (1)
-
Corneal abrasion
-
Other causes of acute red eye (history should aid the diagnosis)
Possible management by optometrist
Advice (1)
-
Time to irrigation is critical and has a major impact on prognosis
-
Irrigation should:
-
Begin immediately at the scene of the accident with any available non-toxic liquid (e.g. tap water)
-
Continue on presentation to clinical care with copious irrigation using sterile saline (≥1 litre initially), or water if saline unavailable
-
-
Continue irrigation for:
-
15–30 minutes, or
-
Until ocular surface pH returns to physiological range (approx. 6.5–7.6)
-
-
When measuring pH:
-
Pause irrigation
-
Wait 5-10 minutes (7)
-
Test the fornix using universal indicator paper
-
Once pH returns to normal, recheck after a further 30 minutes
-
-
Advise no contact lens wear until resolution
Examination (1)
-
Instil topical anaesthetic if required to facilitate irrigation and examination
-
Evert lids (including double eversion where possible), to:
-
Identify and remove retained particulate matter by sweeping fornices with a moistened cotton bud
-
-
Ascertain which chemical caused the injury
-
Assess and record visual acuity (even if challenging to do so)
Treatment
Severe Injury (e.g. limbal ischaemia, corneal opacity) (1)
-
No pharmacological treatment in primary care
-
Emergency referral after irrigation
Mild Injury
-
Ocular lubricants (preferably preservative-free) to aid epithelial healing and symptomatic relief as required (drops/gel for use during the day ± unmedicated ointment for use at bedtime) (1) Refer to local formularies for suitable options (6)
-
Consider topical antibiotic prophylaxis if (1):
-
Significant epithelial defect
-
Risk of contamination
-
-
Consider cycloplegia (e.g. cyclopentolate) for ciliary spasm (1)
-
Recommend simple over the counter pain relief with advice from pharmacist if needed (1,7) and light protection (e.g. sunglasses) (1)
Typical dosage/duration
(Blue text = IP, black text = non-IP)
-
Chloramphenicol 0.5% eye drops (preservative free) (1,5) (POM, off-label): One drop every 2 (waking(7)) hours for 48 hours. After this period, treatment should be every 4 hours during waking hours. Eye drops may be supplemented by 1% ointment at night. The course of treatment should be 5 days (even if symptoms improve) (2,3)
-
Chloramphenicol 1% eye ointment (preservative free) (1,5) (POM, off-label): Apply at night (if eye drops used during the day), alternatively apply 3–4 times daily, if ointment used alone. The course of treatment should be 5 days (even if symptoms improve) (2,3)
-
Cyclopentolate 1% eye drops (preservative free) (1,5) (POM): One drop up to 3 times daily, consider reducing (or stopping) as condition improves (6,7) (consult local guidance as they may vary on timescales)
NB. Chloramphenicol 0.5% eye drops and 1% eye ointment are available via the NHS Pharmacy First service for the treatment of infected eye conditions only and not for prophylactic use in this condition. Where prophylactic antibiotic treatment is clinically indicated, chloramphenicol can be supplied by a prescription or written order. In an emergency situation chloramphenicol (0.5% & 1%) can be supplied to the patient from practice stock if there is no alternative as above (7)
Regimens should be adjusted according to severity and patient factors (e.g. age, weight, pregnancy, renal function). Prescribing should follow local formulary and national guidance where available (7)
In cases of known sensitivities, please consult local formularies for alternative options (7).
Further management options
-
Treatment may be provided within available locally enhanced schemes, or by community IP optometrists/OMPs, as appropriate (7)
Severe Chemical Injury (1)
- First aid (immediate irrigation) followed by emergency referral to A&E / HES
- Contact receiving unit to ensure the patient is expected and prioritised
Mild Chemical Injury (1)
- Alleviation / palliation
- Usually no referral required, provided close monitoring and resolution
Possible management in secondary care or local/community pathways where available
-
See Further management options (1,7)
-
Continued irrigation (1)
-
Inpatient care for severe cases (1)
-
Medical therapy may include (1):
-
Topical antibiotics and corticosteroids
-
Ascorbic acid (topical/systemic)
-
Sodium citrate
-
Oral tetracyclines
-
Systemic IOP-lowering therapy if required
-
-
Additional interventions (1):
-
Bandage contact lens
-
Amniotic membrane transplantation
-
Limbal stem cell transplantation
-
Surgical reconstruction in severe cases
-
College of Optometrists Clinical Management Guideline (1)
Trauma (chemical) - College of Optometrists *
* With special thanks to The College of Optometrists for providing the evidence framework for diagnosis and management from the Clinical Management Guidelines (CMGs) for this condition. All references to the College/CMGs are included where appropriate and form the basis of the Community Eyecare Guidelines.
Guidance is informed by the following sources
-
College of Optometrists Clinical Management Guidelines Clinical Management Guidelines - College of Optometrists
-
Advisory alignment with the College of Optometrists Formulary Optometrists' Formulary - College of Optometrists
-
Advisory alignment with the BNF BNF (British National Formulary) | NICE
-
Advisory alignment with the Summary Product Characteristics taken from the EMC Home - electronic medicines compendium (emc)
-
Advisory alignment with Scottish Health Board formularies (where a clear majority is present) *
-
Advisory alignment with expert consensus (CEGG), informed by sources 2-5 above
-
Advisory alignment with expert consensus (CEGG)
-
“Annex C of the Statement” https://www.eyes.nhs.scot/for-professionals/legislation/
* Scottish formularies should be available within the Prescribing section of your Health Board pages on the eyes.nhs.scot website. If unavailable, contact your local Health Board for further information; Health Boards landing page
If you have a query relating to this page, please email NSS.ComEyecareGuidelineGroup@nhs.scot